| Cas No.: | 1201438-56-3 |
| 名称: | |
| 别名: | IPI145; IPI 145; IPI-145. INK-1197; INK 1197; INK1197,Duvelisib (IPI-145, INK1197) |
| SMILES: | C[C@@H](C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5 |
| 分子式: | C22H17ClN6O |
| 分子量: | 416.86 |
| 纯度: | |
| 保存条件: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | |
| In Vivo: | |
| In Vitro: | |
| References: | IPI-145, also known as INK-1197, is an orally bioavailable, highly selective and potent small molecule inhibitor of the delta and gamma iso Forms of phosphoinositide-3 kinase (PI3K) with potential immunomodulating and antineoplastic activities. Upon admin |
| Kinase Assay: | |
| Cell Assay: | |
| Animal Administration: | |
| References: |
MSDS
COA
| LOT NO. | DOWNLOAD |
|
|
|
| 2018-0101 |
|
